The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma

Objectives. Chemotherapy as first-/second-line treatment in different epidermal growth factor receptor (EGFR) mutation lung adenocarcinoma remains controversial. Methods. Consecutive patients were collected between 2009 and 2012. Patients were divided into two groups (1st-line chemotherapy: n = 56 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Fu-Tsai, Ho, Ming-Yun, Fang, Yueh-Fu, Hshieh, Meng-Heng, Wang, Tsai-Yu, Kuo, Chih-Hsi, Chen, Hao-Cheng, Wang, Chun-Hwa, Lin, Shu-Min, Yu, Chih-Teng, Lin, Horng-Chyuan, Kuo, Han-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644829/
https://www.ncbi.nlm.nih.gov/pubmed/26609535
http://dx.doi.org/10.1155/2015/948267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644829/
https://www.ncbi.nlm.nih.gov/pubmed/26609535
http://dx.doi.org/10.1155/2015/948267

Ejemplares similares